These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33324229)

  • 21. Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.
    Chu Z; Shi X; Chen G; He X; Qian Y; Wang H; Tao L; Liu Y; Jiang W; Chen J
    Front Pharmacol; 2021; 12():831941. PubMed ID: 35069227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.
    Iglesias-Lopez C; Agustí A; Obach M; Vallano A
    Front Pharmacol; 2020; 11():766. PubMed ID: 32523535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: Evaluation of herb-drug interaction between Danshen and rivaroxaban in rat and human liver microsomes.
    Wang X; Fa J; Zhang Y; Huang S; Liu J; Gao J; Xing L; Liu Z; Wang X
    Front Pharmacol; 2022; 13():1039267. PubMed ID: 36278227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum: Machine Learning Enables Accurate and Rapid Prediction of Active Molecules Against Breast Cancer Cells.
    He S; Zhao D; Ling Y; Cai H; Cai Y; Zhang J; Wang L
    Front Pharmacol; 2022; 13():901513. PubMed ID: 35707400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: Mechanism and Management of Fentanyl-Induced Cough.
    Chen R; Tang LH; Sun T; Zeng Z; Zhang YY; Ding K; Meng QT
    Front Pharmacol; 2020; 11():629157. PubMed ID: 33362568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape.
    Xie S; Li S; Tian J; Li F
    Front Pharmacol; 2020; 11():488. PubMed ID: 32372962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicolorful Carbon Dots for Tumor Theranostics.
    Wang H; Bi J; Zhu BW; Tan M
    Curr Med Chem; 2018; 25(25):2894-2909. PubMed ID: 28302015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice.
    Choudhari AS; Mandave PC; Deshpande M; Ranjekar P; Prakash O
    Front Pharmacol; 2020; 11():175. PubMed ID: 32184731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum: Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
    Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
    Front Chem; 2022; 10():919505. PubMed ID: 35646818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between standard and transepithelial corneal crosslinking using a theranostic UV-A device.
    Lombardo G; Serrao S; Lombardo M
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):829-834. PubMed ID: 31900647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction.
    Wang F; Mayca Pozo F; Tian D; Geng X; Yao X; Zhang Y; Tang J
    Front Pharmacol; 2020; 11():1088. PubMed ID: 32765281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum: Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases.
    Garg NK; Tandel N; Bhadada SK; Tyagi RK
    Front Pharmacol; 2022; 13():1002649. PubMed ID: 36091766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents.
    Ladin DA; Soliman E; Griffin L; Van Dross R
    Front Pharmacol; 2021; 12():732903. PubMed ID: 34335283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats.
    Tu C; Gao D; Li XF; Li CY; Li RS; Zhao YL; Li N; Jia GL; Pang JY; Cui HR; Ma ZJ; Xiao XH; Wang JB
    Front Pharmacol; 2020; 11():597772. PubMed ID: 33568998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging vistas in theranostic medicine.
    Shetty Y; Prabhu P; Prabhakar B
    Int J Pharm; 2019 Mar; 558():29-42. PubMed ID: 30599229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Riboflavin Transporters RFVT/SLC52A Mediate Translocation of Riboflavin, Rather than FMN or FAD, across Plasma Membrane.
    Jin C; Yao Y; Yonezawa A; Imai S; Yoshimatsu H; Otani Y; Omura T; Nakagawa S; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2017; 40(11):1990-1995. PubMed ID: 29093349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors.
    Yang C; Du M; Yan F; Chen Z
    Front Pharmacol; 2019; 10():875. PubMed ID: 31413707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine.
    Guin D; Rani J; Singh P; Grover S; Bora S; Talwar P; Karthikeyan M; Satyamoorthy K; Adithan C; Ramachandran S; Saso L; Hasija Y; Kukreti R
    Front Pharmacol; 2020; 11():614445. PubMed ID: 33343377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF-HuR complex.
    Zhu Q; Wang J; Ji Y; Luan J; Yue D; Liu W; Li H; Zhang J; Qu G; Lv C; Song X
    Front Pharmacol; 2022; 13():1086927. PubMed ID: 36534046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.